Literature DB >> 30488801

Systemic Lupus Erythematosus: Symptoms and Signs at Initial Presentations.

Abdel Masieh Metry1, Issa Al Salmi1, Farida Al Balushi2, Mohammed Abdalla Yousef1, Faisal Al Ismaili1, Alan Hola1, Suad Hannawi3.   

Abstract

BACKGROUND: Systemic Lupus Erythematosus (SLE) is an autoimmune multisystem inflammatory condition that causes microvascular inflammation with the production of various auto-antibodies that play a major role in its pathogenesis. SLE can affect both sexes, all ages, and all ethnic groups with widespread geographical and socioeconomic backgrounds. Asia encompasses people of many sociocultural backgrounds with diverse ethnic.
OBJECTIVE: Due to a lack of national epidemiological research, the incidence and prevalence of SLE in Middle Eastern and Arab countries, have only recently been studied. This article aims to explore the status of SLE in Oman and to record symptoms and signs of SLE at first presentation.
METHODOLOGY: Medical records of all patients diagnosed with SLE at the Royal Hospital from 2006 to 2014 were reviewed for information recorded at first visit. SLE diagnosis was based on the American College of Rheumatology classification criteria; ACR97 (which includes the clinical manifestation and laboratory evidence). Patients with SLE disease manifestations extrapolated and analyzed. There were 966 patients diagnosed with SLE during the period from 2006 to 2014. Mean (SD) age at presentations was 35.5 (11.5) years. Majority of patients were female which constitutes 88.7% of the total SLE patients with mean age 27.6 (1.4) years.
RESULTS: Constitutional symptoms were found in 48.68 of SLE population including fatigue in 35.22%, and weight changes in 13.43%. The cutaneous manifestations that were present included malar rash 37.69%, photosensitivity 35.10%, discoid lupus 17.63%, and hair loss 39.29%. Musculoskeletal manifestations were commonly seen among the studied population including arthralgia in 68.75%, myalgia in 55.65%, arthritis in 48.31%, whilst myositis, tendon abnormalities and avascular necrosis were found in only 2.47%, 0.31% and 1.98%. respectively.
CONCLUSION: This is the first study of the symptoms and signs at initial clinical presentation of SLE patients compared to other studies done regionally where most have focused on clinical manifestations during the progression course of SLE. SLE manifestations may be related to the differences in the genetic make-up of the patients who come from various ethnic groups despite similar geography or sociocultural background, or to referral bias, as some studies were performed in the nephrology units and others in the rheumatology units. There is a pressing need to establish a nationwide and regional collaboration to establish LUPUS and to put forward a strategic planning with each MOH to provide an easy and efficient report of SLE cases and provide various effective management for such a debilitating syndrome. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Systemic Lupus Erythematosus (SLE); cardiovascular disease (CVD); cerebrovascular accident (CVA); chronic kidneyzzm321990disease (CKD); diabetes mellitus (DM); end-stage kidney disease (ESKD); hyperlipidemia; hypertension (HTN); lung disease.

Year:  2019        PMID: 30488801     DOI: 10.2174/1871523018666181128161828

Source DB:  PubMed          Journal:  Antiinflamm Antiallergy Agents Med Chem        ISSN: 1871-5230


  6 in total

1.  Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response.

Authors:  Jan-Mou Lee; Ming-Huang Chen; Kai-Yuan Chou; Yee Chao; Ming-Han Chen; Chang-Youh Tsai
Journal:  Lupus Sci Med       Date:  2022-06

2.  Celiac disease in patients with systemic lupus erythematosus.

Authors:  Zahra Soltani; Azarakhsh Baghdadi; Mohammad Nejadhosseinian; Seyedeh Tahereh Faezi; Bijan Shahbazkhani; Seyed Ali Mousavi; Kiarash Kazemi
Journal:  Reumatologia       Date:  2021-04-27

3.  Systemic lupus erythematosus presenting with holocord myelitis.

Authors:  A Kumar; M B Singh; A Garg; V Y Vishnu
Journal:  J Postgrad Med       Date:  2021 Jan-Mar       Impact factor: 1.476

Review 4.  Association between Toxoplasma gondii and systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Pierce Bassett; Brinley N Zabriskie; Ashley Catchpole; Dawson Hedges
Journal:  J Transl Autoimmun       Date:  2022-09-05

5.  Systemic Lupus Erythematosus Presenting as Pulmonary Embolism After Liposuction: A Clinical Conundrum.

Authors:  Aneesh Kumar; Haider Ghazanfar; Faryal Altaf
Journal:  Cureus       Date:  2021-06-30

Review 6.  Mechanistic Paradigms of Natural Plant Metabolites as Remedial Candidates for Systemic Lupus Erythromatosus.

Authors:  Acharya Balkrishna; Pallavi Thakur; Shivam Singh; Swami Narsingh Chandra Dev; Anurag Varshney
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.